Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Nektar Therapeutics (NASDAQ:NKTR)

During the Trading Day
11.40 +0.65 / +6.05%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
11.40 +0.0023 / +0.02%
 
Volume: 21.9K

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for Nektar Therapeutics have a median target of 16.00, with a high estimate of 19.00 and a low estimate of 14.00. The median estimate represents a +40.35% increase from the last price of 11.40.

Analyst Recommendations

The current consensus among 7 polled investment analysts is to Buy stock in Nektar Therapeutics. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.32
Sales
$38.6M
Reporting Date
Nov 05

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 20.42%
 
 
 
 
 
 
Growthannually -39.80%
 
 
 
 
 
 

Sales

Growthquarterly 70.46%
 
 
 
 
 
 
Growthannually 13.16%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.